Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical AKP-11 for arthritis
ACTRN12617001223325Phase 2Recruiting
- Sponsor
- Akaal Pharma Pty Ltd
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of akp-11 in osteoarthritis (OA), rheumatoid arthritis (RA) and gout, sponsored by Akaal Pharma Pty Ltd. Started May 2018; status: recruiting.
02
Drugs
akp-11
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)gout
Beyond the preview
Go deeper on ACTRN12617001223325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001223325.